Description
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Product Unit Size | Cost | Quantity | Stock |
|---|
Matrix GLa protein inhibits vascular calcification in a vitamin K-dependent manner. Serum levels of this peptide may be used as a biomarker for renal failure, diabetes, and cardiovascular events.
| Purity | ≥95% |
|---|---|
| Formula | C18H25N5O5S |
| Formula Wt. | 423.4 |
| Synonym | MGP-pNa |
| Solubility | Soluble in water. |
| Appearance | White to off white powder |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
McCarty MF, DiNicolantonio JJ. The molecular biology and pathophysiology of vascular calcification. Postgrad Med. 2014 Mar;126(2):54-64. PMID: 24685968.
Schurgers LJ, Uitto J, Reutelingsperger CP. Vitamin K-dependent carboxylation of matrix Gla-protein: a crucial switch to control ectopic mineralization. Trends Mol Med. 2013 Apr;19(4):217-26. PMID: 23375872.
Macrolide antibiotic; peptidyl transferase inhi...
JAK1/2 inhibitor.
ACE inhibitor.
Steroid; glucocorticoid agonist.
HEXIM1 activator.
Endogenous peptide hormone, increases extracell...
NSAID; CB1 agonist, COX-2 inhibitor.
5-Fluorouracil prodrug, pyrimidine nucleoside a...
Semi-synthetic avermectin; GABA potentiator.
AurKA/B inhibitor.
Triazole; 14-α demethylase inhibitor, potentia...
Potential AhR binding agent.
Synthetic steroid, contraceptive; PR and glucoc...
Synthetic steroid hormone; ER agonist.
Endogenous tachykinin peptide, involved in infl...
Fluoroquinolone, optically active isomer of ofl...
Stearoyl-coA desaturase 1 inhibitor.
Triterpenoid
Statin; HMG-CoA reductase inhibitor.
Rapamycin analog